Medical oxygen is an essential component of healthcare, especially in critical care settings. The COVID-19 pandemic has highlighted the importance of having a reliable and accessible supply of medical oxygen to treat patients with severe respiratory distress. In low- and middle-income countries, including those in East Africa, there is a significant shortage of medical oxygen, which has contributed to the high mortality rate of COVID-19 patients.
According to a report by Grand View Research, the global medical oxygen market size was valued at USD 2.8 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 7.4% from 2021 to 2028. The report highlights the growing demand for medical oxygen due to the increasing prevalence of respiratory diseases, especially among the aging population, and the surge in COVID-19 cases.
In East Africa, there have been initiatives to improve the availability of medical oxygen, such as the Oxygen for Life Initiative by the Clinton Health Access Initiative, which aims to increase the supply of medical oxygen in hospitals and health facilities in Ethiopia, Kenya, Nigeria, and Tanzania. However, there is still a long way to go to ensure that medical oxygen is accessible to all who need it in the region.
Overall, while I cannot provide specific information on the growth of the East Africa medical oxygen market by 2030, the global market for medical oxygen is expected to grow, and there is a significant need to improve the accessibility and availability of medical oxygen in low- and middle-income countries, including those in East Africa.